The Daily Molecule

Bremelanotide (formerly PT-141) is the generic term for a new medication for use in treating sexual dysfunction in men (erectile dysfunction or impotence) as well as sexual dysfunction in women (sexual arousal disorder). It is the only known synthetic aphrodisiac. Unlike Sildenafil and other related medications, it does not act upon the vascular system, but directly increases sexual desire. Bremelanotide is a spray introduced nasally.

References

• Tanning drug may find new life as Viagra alternative

• Palatin Technologies Announces New Strategic Objectives

• Selective facilitation of sexual solicitation in the female rat by a melanocortin receptor agonist

This article is licensed under the GNU Free Documentation License and uses material from the Wikipedia article Bremelanotide.